Royce & Associates
TDOC icon

Royce & Associates’s Teladoc Health TDOC Stock Holding History

Royce & Associates’s Portfolio TDOC Stock Details TDOC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$102K Buy
17,608
+4,696
+36% +$34.4K ﹤0.01% 765
2026
Q2 		$109K Buy
+12,912
New +$85.9K ﹤0.01% 732
2024
Q4 		– Sell
-18,189
Closed -$167K – 902
2024
Q3 		$167K Buy
+18,189
New +$151K ﹤0.01% 839

Other funds holding TDOC

Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $85.7B AUM 51.02% 1-Year Est. Return
Jupiter Asset Management
Jupiter Asset Management London, United Kingdom $21.4B AUM 19.74% 1-Year Est. Return
Monaco Asset Management
Monaco Asset Management Monaco $818M AUM 32.61% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Counterpoint Mutual Funds
Counterpoint Mutual Funds San Diego, California $1.16B AUM 33.78% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
TCW Group
TCW Group Los Angeles, California $13B AUM 38.16% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return

Royce & Associates's TDOC Position: Q3 2026 in Review

Royce & Associates increased its Teladoc Health (TDOC) stake by 36% in Q3 2026, buying an estimated $34.4K and bringing the position to 17,608 shares worth $102K. The position accounts for ﹤0.01% of the portfolio, ranked #765.

Royce & Associates first reported a position in TDOC in Q3 2024 and has held it in 3 quarters since. The position peaked at $167K in Q3 2024. 175 funds tracked by Wall St. Rank hold TDOC as of Q3 2026.

  • Royce & Associates held 17,608 shares of Teladoc Health worth $102K as of Q3 2026.
  • Royce & Associates bought 4,696 Teladoc Health shares in Q3 2026, an estimated $34.4K.
  • Teladoc Health made up ﹤0.01% of Royce & Associates's portfolio in Q3 2026, its #765 holding.
  • Royce & Associates first reported a position in Teladoc Health in Q3 2024 and has held it in 3 quarters since.
  • Royce & Associates's Teladoc Health position peaked at $167K in Q3 2024.
  • 175 funds tracked by Wall St. Rank held Teladoc Health as of Q3 2026.

Based on Royce & Associates's 13F filing for Q3 2026, filed 9 Nov 2026.